PolarityTE Inc (PTE) - Product Pipeline Analysis, 2021 Update

PolarityTE Inc (PTE) - Product Pipeline Analysis, 2021 Update

Summary

PolarityTE Inc (PolarityTE) is a commercial-stage biotechnology company. The company designs, discovers, develops, and commercializes a range of products including regenerative tissues and biomaterials. Its products are used in fields of biomedical engineering, material sciences, and medicine. The company’s products are based on minimally polarized functional units (MPFUs) which include self-complexing intelligent regenerative materials. Its flagship product, SkinTE, is indicated for the treatment of defects of the skin and is created from a small piece of the patient’s own tissue. PolarityTE pipeline products serve the replacement or reconstruction requirements of face, wrist, arteriovenous fistula, hand, joints, breast, urethra, buttocks, bowel tissue, and bladder surgical resection of the liver. The company also offers contract research services including veterinary and preclinical services, advanced imaging, biomedical engineering and validation, molecular biology assays and proteomics analyses. PolarityTE is headquartered in Salt Lake City, Utah, the US..

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

• The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
• The report analyzes all pipeline products in development for the company PolarityTE Inc
• The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
• The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
• The report provides detailed description of products in development, technical specification and functions
• The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

• Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
• Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
• To formulate effective Research & Development strategies
• Develop market-entry and market expansion strategies
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
• Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note:Some sections may be missing if data is unavailable for the company

Companies Mentioned

Avita Medical Inc
Osiris Therapeutics Inc
Dermagraft
Integra LifeSciences Corp
AlloSource
Wright Medical Group, Inc.
MTF Biologics
Organogenesis Holdings Inc
MiMedx Group Inc
Vericel Corp